Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis
Clinical trial NCT00141102 · COMPLETED
Trial details
- NCT number
- NCT00141102
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2009-05-01
- Enrollment
- 4484
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.